Browse the evidence

Ether-linked phosphatidylethanolamines (specifically PE-P and PE-O) are associated with lower insulin resistance (SSPG) and healthier metabolic profiles, contrasting with other lipid classes like Ceramides and TAGs which increase with IR.

Not all phosphatidylethanolamines are equal. Ether-linked forms (PE-P and PE-O) are associated with lower insulin resistance, while standard PEs and Ceramides are linked to higher resistance. This highlights the importance of lipid subclass specificity in metabolic health.

High-intensity physical activity, particularly when performed in the evening or close to bedtime, is associated with poor sleep quality and difficulty initiating sleep.

If you exercise in the evening, avoid high-intensity workouts within 3 hours of bedtime. Opt for moderate intensity or finish your session earlier in the evening. High-intensity or long-duration (>90 min) evening exercise is linked to poorer sleep quality.

Oral L-citrulline supplementation (3–10 g/day) effectively increases plasma L-arginine and nitric oxide (NO) bioavailability, leading to reduced resting blood pressure and arterial stiffness in pre-hypertensive and hypertensive populations, whereas it fails to improve endothelial function (FMD) in healthy young individuals.

If you have high blood pressure, taking 3-10 grams of L-citrulline daily (or eating equivalent amounts of watermelon) can help lower your blood pressure and improve artery stiffness. This works best if you are already pre-hypertensive or hypertensive. If you are young and healthy, you likely won't see changes in your blood vessel dilation, so don't expect performance benefits from this specific mechanism.

Severe sedentary behavior increases the risk of sleep disturbance, and this association is significantly mediated by elevated blood-cell-based inflammatory biomarkers (WBC, NEU, NLR, SII).

If you sit for more than 480 minutes a day (severe sedentary behavior), your risk of sleep disturbance increases. This risk is partly driven by your body's inflammatory response (measurable by blood tests). To mitigate this, you must break up long periods of sitting with movement, as this reduces the inflammatory burden that disrupts sleep.

In postmenopausal women with a normal body mass index (BMI 18.5–24.9), higher levels of body fat (specifically whole-body and trunk fat) are associated with a significantly elevated risk of invasive breast cancer, particularly estrogen receptor-positive (ER+) subtypes.

If you are a postmenopausal woman with a normal BMI, your body fat percentage still matters for breast cancer risk. High body fat, especially around the trunk, is linked to a significantly higher risk of ER-positive breast cancer, even if your weight is healthy. Focus on maintaining healthy body fat levels through diet and exercise, rather than just focusing on BMI.

Lifestyle modification and metformin treatment can modulate gut microbiota and maintain glucose homeostasis in type 2 diabetes, suggesting similar potential for post-GDM women.

For post-GDM women, lifestyle changes and metformin have been shown to help manage blood sugar and potentially improve gut bacteria. However, adherence to lifestyle changes is often poor after delivery, and metformin's use as a preventive strategy is still debated. Prioritize sustainable lifestyle habits.

Semaglutide (1.0 mg once-weekly) significantly improves fasting and postprandial glucose and lipid metabolism in subjects with obesity, primarily through delayed first-hour gastric emptying and GLP-1 receptor agonism.

For individuals with obesity, semaglutide (1.0 mg weekly) significantly improves how the body handles glucose and fats after eating. This is achieved by slowing down the initial emptying of the stomach, which prevents rapid spikes in blood sugar and lipids. This benefit occurs even in people without diabetes, suggesting it may be a valuable tool for metabolic health in obesity.

Magnesium deficiency contributes to insulin resistance and type 2 diabetes through impaired insulin signaling, specifically by altering the PI3K/Akt pathway and KATP channel regulation in pancreatic beta cells.

Maintaining adequate magnesium levels is crucial for proper insulin function. Low magnesium disrupts the cellular machinery that allows insulin to work, contributing to the development of type 2 diabetes.

Caffeine consumption (particularly >200 mg) disrupts sleep quality and quantity by reducing melatonin metabolites and shifting sleep architecture, leading to next-day performance deficits.

If you consume caffeine, be aware that it can disrupt your sleep even if you stop 6 hours before bed. This disruption leads to next-day performance deficits. To mitigate this, limit caffeine intake to early morning hours or reduce total daily dosage, especially if you are sensitive to sleep loss.

Caffeine administration after sleep deprivation caused by prior caffeine use can reverse performance deficits, often resulting in a net benefit for psychomotor and cognitive tasks, though this may be partly due to the reversal of withdrawal symptoms.

Caffeine can effectively counteract the performance deficits caused by sleep deprivation, particularly for vigilance and reaction time tasks. However, it may not improve complex motor skills like marksmanship. Use caffeine strategically to maintain performance during sleep-deprived periods, but recognize that it does not replace the need for sleep.

Sarcopenic obesity (SO) creates a synergistic, vicious cycle with diabetes where insulin resistance accelerates muscle catabolism and loss of muscle mass worsens insulin sensitivity, leading to significantly higher all-cause mortality and metabolic disorder risks than either condition alone.

If you have excess body fat and low muscle mass/strength, standard weight loss advice may be harmful. Focus on preserving muscle through adequate protein (1-1.2 g/kg/day for older adults) and resistance training, rather than just caloric restriction. This combination is critical to breaking the cycle of insulin resistance and reducing mortality risk.

Low-grade inflammation driven by adipose tissue expansion (secreting TNF-a, IL-6, leptin) directly contributes to insulin resistance and muscle protein catabolism, accelerating the progression of sarcopenic obesity.

Managing inflammation through lifestyle (diet, activity) is part of treating SO, as fat tissue actively secretes hormones that break down muscle and block insulin.

High psychological distress (stress, anxiety, depression) during COVID-19 lockdown significantly increases the probability of poor sleep quality in adults.

If you are experiencing high levels of stress, anxiety, or depression during a crisis, prioritize sleep hygiene immediately. The data shows that severe distress drastically increases the odds of poor sleep. Managing your mental state is not just about mood; it is a direct physiological lever for protecting your sleep quality.

Disruptions to circadian rhythms, specifically changes in habitual bedtime (earlier or later) and awakening time, are significant risk factors for poor sleep quality during lockdown.

Maintain consistent bedtimes and wake times, even when working from home. The data shows that shifting your sleep schedule (either earlier or later) significantly increases the risk of poor sleep. Regularity is more important than total hours when it comes to sleep quality.

Acute exercise induces a transient suppression of appetite (exercise-induced anorexia) and does not stimulate compensatory increases in energy intake on the day of exercise, regardless of whether the individual is lean or has overweight/obesity.

You can exercise to create a calorie deficit without worrying that you will automatically eat back the calories burned on the same day. While you might feel less hungry during and immediately after the workout, this effect is temporary and does not lead to overeating later. This holds true whether you are lean or have overweight/obesity.

Low energy availability (EA <30 kcal/kg FFM/day) causes functional hypothalamic amenorrhea (FHA) in female athletes through suppressed GnRH pulsatility, leading to decreased estradiol and progesterone.

If you are a female athlete experiencing missed periods, check your energy intake relative to your exercise expenditure. If your energy availability is consistently below 30 kcal per kg of fat-free mass per day, you are at high risk for hormonal suppression. Consult a specialist to address this before bone health is compromised.

Low energy availability suppresses leptin levels and elevates ghrelin and peptide YY (PYY), disrupting appetite regulation and contributing to the maintenance of low energy states.

Low energy intake changes your hunger hormones: leptin drops, ghrelin and PYY rise. This can make it harder to feel hunger cues accurately and may contribute to disordered eating patterns. Prioritize regular, adequate meals to normalize these hormones.

Low energy availability leads to decreased IGF-1 and increased GH, indicating GH resistance at the liver, which impairs bone and muscle anabolism.

If you are under-fueled, your body may produce more GH but fail to use it effectively (GH resistance), leading to low IGF-1. This impairs bone and muscle health. Restoring energy intake can help normalize this axis.

Omega-3 polyunsaturated fatty acids (EPA, DHA, DPA) exert anti-inflammatory and pro-resolving effects by being metabolized into specialized pro-resolving mediators (SPMs) such as resolvins, protectins, and maresins, which actively terminate inflammation and promote tissue regeneration rather than merely suppressing immune responses.

Consuming omega-3 fatty acids (EPA, DHA, DPA) supports the body's active resolution of inflammation through specialized mediators like resolvins and protectins. This process helps clear cellular debris, promotes tissue regeneration, and regulates immune responses, offering a pathway to manage chronic inflammatory states associated with diseases like cardiovascular issues and autoimmune disorders.

Gut microbiota composition directly influences host glycemic control and insulin sensitivity through mechanisms including incretin secretion, short-chain fatty acid (SCFA) production, and bile acid metabolism.

Your gut bacteria play a key role in how your body handles sugar. Eating non-digestible carbohydrates (like inulin and oligofructose) can feed beneficial bacteria that produce short-chain fatty acids and stimulate hormones (GLP-1) that improve insulin response. This suggests that dietary fiber is not just for digestion but is a metabolic tool for glycemic control.

Prebiotic supplementation with non-digestible carbohydrates (e.g., oligofructose, inulin) improves glucose tolerance and insulin response by increasing GLP-1 secretion and SCFA production.

Incorporate prebiotic fibers like inulin or oligofructose into your diet. These are found in foods like chicory root, garlic, and onions, or taken as supplements. They feed gut bacteria that produce beneficial compounds (SCFAs) and stimulate hormones (GLP-1) that help lower blood sugar and reduce appetite.

Blocking myostatin/activin signaling (via ActRIIB blockade) promotes muscle hypertrophy and can reverse cancer cachexia by inhibiting SMAD2/3 signaling and stimulating SMAD1/5/8 pathways.

For those struggling with severe muscle loss, such as in cancer cachexia, therapies that block myostatin/activin signaling show promise in preserving and even increasing muscle mass. This approach targets the root cause of excessive muscle breakdown rather than just stimulating synthesis.

Incretin stimulation via GLP-1 receptor agonists (e.g., liraglutide, exenatide) and DPP-4 inhibitors reduces visceral and epicardial adipose tissue volume and thickness while promoting the browning of white adipocytes, thereby alleviating insulin resistance and associated cardiovascular pathologies in obese and type-2 diabetic patients.

For patients with obesity and Type-2 Diabetes, GLP-1 receptor agonists (like liraglutide) and DPP-4 inhibitors are effective pharmacological tools to specifically target dangerous visceral and epicardial fat. Unlike Metformin, these drugs significantly shrink epicardial fat thickness, which is linked to cardiovascular risk. This reduction in fat volume, combined with improved insulin sensitivity, offers a targeted approach to preventing heart disease in this population.

Bariatric surgeries, specifically Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG), reduce fasting plasma LEAP2 levels in humans with obesity, correlating with weight loss and improved metabolic markers.

Bariatric surgeries like RYGB and VSG lower levels of the hormone LEAP2, which is typically high in obesity. This hormonal shift, along with weight loss, may help maintain the weight loss by altering hunger signaling. This suggests that surgery works partly by resetting hormonal balances.